▶ 調査レポート

世界のヒドロキシクロロキン薬市場2020年-2030年:疾患別(マラリア、関節リウマチ、COVID-19、全身性エリテマトーデス、その他)、流通チャンネル別

• 英文タイトル:Hydroxychloroquine Drugs Market (Disease Indication: Malaria, Rheumatoid Arthritis, COVID-19, Systemic Lupus Erythematosus, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Hydroxychloroquine Drugs Market (Disease Indication: Malaria, Rheumatoid Arthritis, COVID-19, Systemic Lupus Erythematosus, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030「世界のヒドロキシクロロキン薬市場2020年-2030年:疾患別(マラリア、関節リウマチ、COVID-19、全身性エリテマトーデス、その他)、流通チャンネル別」(市場規模、市場予測)調査レポートです。• レポートコード:MRC21A39
• 出版社/出版日:Transparency Market Research / 2020年11月27日
• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥822,890 (USD5,795)▷ お問い合わせ
  Site Licence (同一拠点内共用可)¥1,248,890 (USD8,795)▷ お問い合わせ
  Enterprise wide(複数拠点共用可)¥1,674,890 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートは、世界のヒドロキシクロロキン薬市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、市場展望、疾患別(マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他)分析、流通チャンネル別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・市場展望
・世界のヒドロキシクロロキン薬市場規模:疾患別(マラリア、関節リウマチ、新型コロナウイルス感染症、全身性エリテマトーデス、その他)
・世界のヒドロキシクロロキン薬市場規模:流通チャンネル別
・世界のヒドロキシクロロキン薬市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)
・競争状況

Hydroxychloroquine Drugs Market – Scope of the Report

TMR’s report on the global hydroxychloroquine drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global hydroxychloroquine drugs market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hydroxychloroquine drugs market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global hydroxychloroquine drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global hydroxychloroquine drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global hydroxychloroquine drugs market. These serve as valuable tools for existing market players as well as entities interested in participating in the global hydroxychloroquine drugs market.

The report also delves into the competition landscape of the global hydroxychloroquine drugs market. Key players operating in the global hydroxychloroquine drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hydroxychloroquine drugs market that have been profiled in this report.

Key Questions Answered in Hydroxychloroquine Drugs Report

What is the sales/revenue generated by hydroxychloroquine drug providers across all regions during the forecast period?
What are the opportunities in the global hydroxychloroquine drugs market?
What are the major drivers, restraints, and threats in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which distribution channel segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Hydroxychloroquine Drugs Market – Research Objectives and Research Approach

The comprehensive report on the global hydroxychloroquine drugs market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of distribution channels.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hydroxychloroquine drugs market in terms of disease indication, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global hydroxychloroquine drugs market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hydroxychloroquine Drugs Market

4. Market Overview

4.1. Introduction & Overview

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Global Hydroxychloroquine Drugs Market Analysis and Forecast, 2018–2030

5. Market Outlook

5.1. COVID-19 Pandemics Impact on Industry

5.2. Regulatory Scenario by Region/globally

5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Disease Indication

6.1. Introduction & Definition

6.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

6.2.1. Malaria

6.2.2. Rheumatoid Arthritis

6.2.3. COVID-19

6.2.4. Systemic Lupus Erythematosus

6.2.5. Others

6.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Disease Indication

7. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Distribution Channel

7.1. Introduction & Definition

7.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

7.2.1. Hospital Pharmacies

7.2.2. Retail Pharmacies

7.2.3. Online Pharmacies

7.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Distribution Channel

8. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Region

9. North America Hydroxychloroquine Drugs Market Analysis and Forecast

9.1. Introduction

9.2. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

9.2.1. Malaria

9.2.2. Rheumatoid Arthritis

9.2.3. COVID-19

9.2.4. Systemic Lupus Erythematosus

9.2.5. Others

9.3. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America Hydroxychloroquine Drugs Market Attractiveness Analysis

9.5.1. By Disease Indication

9.5.2. By Distribution Channel

9.5.3. By Country

10. Europe Hydroxychloroquine Drugs Market Analysis and Forecast

10.1. Introduction

10.2. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

10.2.1. Malaria

10.2.2. Rheumatoid Arthritis

10.2.3. COVID-19

10.2.4. Systemic Lupus Erythematosus

10.2.5. Others

10.3. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Hydroxychloroquine Drugs Market Attractiveness Analysis

10.5.1. By Disease Indication

10.5.2. By Distribution Channel

10.5.3. By Country/Sub-region

11. Asia Pacific Hydroxychloroquine Drugs Market Analysis and Forecast

11.1. Introduction

11.2. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

11.2.1. Malaria

11.2.2. Rheumatoid Arthritis

11.2.3. COVID-19

11.2.4. Systemic Lupus Erythematosus

11.2.5. Others

11.3. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Hydroxychloroquine Drugs Market Attractiveness Analysis

11.5.1. By Disease Indication

11.5.2. By Distribution Channel

11.5.3. By Country/Sub-region

12. Latin America Hydroxychloroquine Drugs Market Analysis and Forecast

12.1. Introduction

12.2. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

12.2.1. Malaria

12.2.2. Rheumatoid Arthritis

12.2.3. COVID-19

12.2.4. Systemic Lupus Erythematosus

12.2.5. Others

12.3. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Hydroxychloroquine Drugs Market Attractiveness Analysis

12.5.1. By Disease Indication

12.5.2. By Distribution Channel

12.5.3. By Country/Sub-region

13. Middle East & Africa Hydroxychloroquine Drugs Market Analysis and Forecast

13.1. Introduction

13.2. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

13.2.1. Malaria

13.2.2. Rheumatoid Arthritis

13.2.3. COVID-19

13.2.4. Systemic Lupus Erythematosus

13.2.5. Others

13.3. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness Analysis

13.5.1. By Disease Indication

13.5.2. By Distribution Channel

13.5.3. By Country/Sub-region

14. Competitive Landscape

14.1. Market Position Analysis, by Company, 2019

14.2. Company Profiles

14.2.1. Sanofi

14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.1.2. Growth Strategies

14.2.1.3. SWOT Analysis

14.2.2. Amneal Pharmaceuticals, Inc.

14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.2.2. Growth Strategies

14.2.2.3. SWOT Analysis

14.2.3. Mylan N.V.

14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.3.2. Growth Strategies

14.2.3.3. SWOT Analysis

14.2.4. Teva Pharmaceutical Industries Ltd.

14.2.4.1. Company Overview (HQ, Business Segments)

14.2.4.2. Growth Strategies

14.2.4.3. SWOT Analysis

14.2.5. Novartis AG

14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.5.2. Growth Strategies

14.2.5.3. SWOT Analysis

14.2.6. Zydus Cadila

14.2.6.1. Company Overview (HQ, Business Segments)

14.2.6.2. Growth Strategies

14.2.6.3. SWOT Analysis

14.2.7. Dr. Reddy’s Laboratories Ltd.

14.2.7.1. Company Overview (HQ, Business Segments)

14.2.7.2. Growth Strategies

14.2.7.3. SWOT Analysis

14.2.8. Sun Pharmaceutical Industries Ltd.

14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.8.2. Growth Strategies

14.2.8.3. SWOT Analysis

14.2.9. Lupin Limited

14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.9.2. Growth Strategies

14.2.9.3. SWOT Analysis

14.2.10. Prasco Laboratories

14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.2.10.2. Company Financials

14.2.10.3. Growth Strategies

14.2.10.4. SWOT Analysis

List of Tables

Table 01: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 02: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 03: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 04: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country, 2018–2030

Table 05: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 06: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 07: Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 08: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 09: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 10: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 11: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 12: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 13: Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 15: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 16: Middle East & Africa Remote Patient Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018–2030

Table 18: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018–2030